Purchase of prolacta breastmilk fortification products for premature infants in the neonatal intensive care unit at tripler army medical center
Ended Awarded Last action
- Contract number
- HT009026FG0170001
- Awardee
-
Prolacta Bioscience, Inc. UEI VJUKD4ELEKD6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,839
Award facts
- Contract value 100% obligated
- $24,838.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- City of Industry, CA 91746, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $24,838.78 firm fixed price Blanket Purchase Agreement call to Prolacta Bioscience, Inc. on January 12, 2026, for the procurement of breastmilk fortification products for premature infants in the Neonatal Intensive Care Unit at Tripler Army Medical Center. This contract, which carries an ultimate completion date of September 30, 2026, was issued with no set-aside designation. Prolacta Bioscience, based in City of Industry, California, specializes in human milk-based nutritional products engineered specifically to meet the complex dietary requirements of extremely low birth weight and premature infants requiring intensive care.
This award represents a task order against one of three existing Indefinite Delivery Vehicles that the Defense Health Agency maintains with Prolacta Bioscience, reflecting the agency's ongoing strategic reliance on the contractor's specialized expertise in neonatal nutrition. The company's federal contract portfolio is exclusively dedicated to supporting military medical facilities through the provision of human milk-derived fortifiers, donor human milk, and specialized infant formulas. The Defense Health Agency's sustained investment in Prolacta Bioscience's human milk-based products underscores the military healthcare system's commitment to delivering advanced nutritional support for at-risk neonatal populations within its facilities.
Quick answers
Who was awarded contract HT009026FG0170001?
HT009026FG0170001 was awarded to Prolacta Bioscience, Inc. by Defense Health Agency (Department of Defense) on January 12, 2026.
How much is contract HT009026FG0170001 worth?
The government has obligated $24,839 on HT009026FG0170001.
Is contract HT009026FG0170001 an order under another contract?
Yes. HT009026FG0170001 is a BPA call under W81K0222A0010, a blanket purchase agreement.
Was contract HT009026FG0170001 competed?
The extent of competition for HT009026FG0170001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award